MassBio

#MassBioMember Spotlight: ABI-LAB stands out as an exciting force in the life-science ecosystem by offering private turnkey, custom-outfitted BSL-2 lab suites designed for companies to move in today and start their science tomorrow. Read more: massbio.org/news/recent-ne…

Guest blogger Rob Patten shares how his professional journey in biotech started years ago, when he was moved to action after a colleague's daughter's diagnosis. Today, his professional biotech community is coming together to support his family's journey: massbio.org/news/recent-ne…

Massachusetts: The State of Possible This year's #StateofPossible26 Conference was a gathering of industry leaders, patient advocates, and government officials around the theme of Behind the Breakthrough. View all sessions now on #MBVision - mbvision.massbio.org/Search?channel…

From Models to Medicines: AI Tools Powering Drug Discovery (Boston) @MassBio, @a16z, and @EliLillyandCo co-hosting. lilly is showcasing TuneLab (their AI/ML drug discovery platform) alongside a16z portcos doing live AI demos. agentic systems for drug discovery, on stage. don't sleep on this one. partiful.com/e/x7APx6PtGOrO…

#MassBioMember Spotlight: ITF Therapeutics was established in January 2024 as the U.S. rare disease affiliate of Italfarmaco, a global pharmaceutical company based in Milan. Read more: massbio.org/news/recent-ne…

@CullinanTx @TaihoOncology Congratulations!

In partnership with @TaihoOncology and Taiho Pharmaceutical, the FDA accepted our NDA for zipalertinib for locally advanced or metastatic EGFR exon 20 insertion NSCLC following platinum‑based chemotherapy. Learn more: investors.cullinantherapeutics.com/news-releases/…

Congratulations to MassBio's Kendalle Burlin O'Connell on once again being named to Boston Magazine's 150 Most Influential Bostonians list.👏 @KendalleOC @BostonMagazine

"There are people behind the scenes that are making a calculation on how long you're going to live. And because of that, they treat you a certain way..." Powerful speech from Sen. @SalDiDomenico - watch the full session on #MBVision: mbvision.massbio.org/Play?pId=c3a25…

At the #StateofPossible26 Conference, a critical question emerged: What threatens our leadership, and what must we do to protect it? Read the blog recapping the conversation with Christopher Viehbacher, Noubar Afeyan, and Gov. Healey: massbio.org/news/recent-ne…

R&D leaders who are advancing cell and gene therapies, RNA-based therapeutics, protein and peptide engineering, and other next-generation platforms will gather for 𝐑&𝐃 𝐑𝐞𝐢𝐦𝐚𝐠𝐢𝐧𝐞𝐝: 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐝 𝐌𝐨𝐝𝐚𝐥𝐢𝐭𝐢𝐞𝐬 on May 11. Join us: massbio.org/events/rd-reim…

80-hour weeks. Years of work that might not pan out. This is the story behind every medicine that reaches a patient. The patients are still waiting. The mission hasn’t changed. #BehindTheBreakthrough | @biogen @bmsnews @ValoHealth

How efficient are your lab operations? In this guest blog from our #MassBioEdge preferred partner @MiddlesexGases they share the top 6 ways to help save money and time in your life sciences lab. Read the blog: massbio.org/news/recent-ne…

Last night, we hosted our second #CEOFounderLink event of the year with Termeer Institute! Thank you to our Link members for attending, and to our featured speakers. Apply to join the Link to attend future events: massbio.org/innovation/ceo…

Some of the most important medicines in history were discovered after teams were told to stop. They kept going anyway. Breakthroughs aren’t easy. They’re earned. #BehindTheBreakthrough

#MassBioMember Spotlight: @AristaNetworks is an industry leader in cloud and AI-driven networking, delivering high-performance, software-defined solutions for data center, campus, and routing environments. Read more: massbio.org/news/recent-ne…

A breakthrough doesn’t start with an answer. It starts when the experts hit the wall—and someone decides that’s exactly where to go. #BehindTheBreakthrough #StateofPossible26 | @rvjee @Precede_Bio @biogen @kano_tx

.@McDermottLaw led this evening's General Counsel Roundtable discussion on "IP Strategy from Preclinical Through Clinical." Thank you to our speaker, co-chairs, and #MassBioMember attendees! Learn more and apply to attend one of our next roundtables: @McDermottLaw" target="_blank" rel="nofollow noopener">massbio.org/?event_search_…

You've likely seen one word dominate recent headlines: Affordability. At MassBio's State of Possible Conference, our panelists had an honest conversation about what it actually costs to innovate — and what it costs not to. Read the full recap: massbio.org/news/recent-ne…

Great to see our CEO Jo Viney, Ph.D. offering her perspective as a panelist on Building Great Companies by Building Great Leaders: Culture as Strategy. Thanks to event co-hosts MassBio and the Termeer Institute. #ceofounderlink #SeismonautsInAction

Watch the full panel discussion, "Voices of Advocacy: Policy, Patients, and the Power of Massachusetts Innovation," and all sessions from the event on MB Vision: mbvision.massbio.org/Play?pId=ac82a… #PatientDriven #MBVision

How can you be sure your doctor is accessing the best technology possible when you receive a diagnosis? As Rep. Meghan Kilcoyne notes, depending on your insurance plan, you may not have the same access to a biomarker test as someone else in the Commonwealth.